Crossmark

Extracellular cardiac matrix biomarkers in patients with reduced ejection fraction heart failure as predictors of response to cardiac resynchronisation therapy: a systematic review

Crossref DOI link: https://doi.org/10.1136/openhrt-2017-000639

Published Online: 2017-08-21

Published Print: 2017-08

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

McAloon, Christopher J

Ali, Danish

Hamborg, Thomas

Banerjee, Prithwish https://orcid.org/0000-0001-7793-1733
O'Hare, Paul

Randeva, Harpal

Osman, Faizel
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct15019908 at ClinicalTrials.gov

Documents that mention this clinical trial

Extracellular cardiac matrix biomarkers in patients with reduced ejection fraction heart failure as predictors of response to cardiac resynchronisation therapy: a systematic review
https://doi.org/10.1136/openhrt-2017-000639

nct15019908 at ClinicalTrials.gov

Documents that mention this clinical trial

Extracellular cardiac matrix biomarkers in patients with reduced ejection fraction heart failure as predictors of response to cardiac resynchronisation therapy: a systematic review
https://doi.org/10.1136/openhrt-2017-000639

Document is current

Any future updates will be listed below